Anixa Biosciences, Inc. SEC filings ANIX

Anixa Biosciences, Inc. has 983 filings in SEC EDGAR's recent list, going back to Jun 9, 1995. Its latest annual report, Form 10-K, was filed on Jan 12, 2026 for the period ended Oct 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 9, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Mar 11, 2026 (shareholder vote results, regulation fd disclosure). The company's fiscal year ends on October 31.

Anixa Biosciences, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Sep 9, 2026 Jul 31, 2026
10-Q Quarterly report Jun 10, 2026 Apr 30, 2026
8-K Current report
Shareholder vote results, Regulation FD disclosure
Mar 11, 2026 Mar 10, 2026
10-Q Quarterly report Mar 9, 2026 Jan 31, 2026
8-K Current report
Regulation FD disclosure
Feb 9, 2026 Feb 9, 2026
DEF 14A Proxy statement Jan 28, 2026 Jan 28, 2026
S-8 Employee stock plan registration Jan 12, 2026 —
10-K Annual report Jan 12, 2026 Oct 31, 2025
8-K Current report
Regulation FD disclosure
Dec 12, 2025 Dec 11, 2025
EFFECT Filing Sep 30, 2025 —
CORRESP Letter to the SEC Sep 26, 2025 —
UPLOAD Letter from the SEC Sep 16, 2025 —
S-3 Shelf registration Sep 10, 2025 —
10-Q Quarterly report Sep 10, 2025 Jul 31, 2025
10-Q Quarterly report May 28, 2025 Apr 30, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
Mar 21, 2025 Mar 20, 2025
10-Q Quarterly report Mar 11, 2025 Jan 31, 2025
DEF 14A Proxy statement Feb 6, 2025 Oct 31, 2024
S-8 Employee stock plan registration Jan 10, 2025 —
10-K Annual report Jan 10, 2025 Oct 31, 2024
8-K Current report
Regulation FD disclosure
Nov 8, 2024 Nov 8, 2024
10-Q Quarterly report Sep 6, 2024 Jul 31, 2024
10-Q Quarterly report Jun 4, 2024 Apr 30, 2024
8-K Current report
Material agreement, Regulation FD disclosure
May 8, 2024 May 3, 2024
8-K Current report
Shareholder vote results, Regulation FD disclosure
Mar 22, 2024 Mar 21, 2024
10-Q Quarterly report Mar 12, 2024 Jan 31, 2024
DEF 14A Proxy statement Feb 8, 2024 Feb 8, 2024
S-8 Employee stock plan registration Jan 16, 2024 —
10-K Annual report Jan 16, 2024 Oct 31, 2023
8-K Current report
Regulation FD disclosure
Dec 7, 2023 Dec 6, 2023
10-Q Quarterly report Sep 6, 2023 Jul 31, 2023
10-Q Quarterly report Jun 14, 2023 Apr 30, 2023
8-K Current report
Regulation FD disclosure
Apr 17, 2023 Apr 17, 2023
10-Q Quarterly report Mar 17, 2023 Jan 31, 2023
8-K Current report
Shareholder vote results, Regulation FD disclosure
Mar 10, 2023 Mar 9, 2023
DEF 14A Proxy statement Jan 27, 2023 Jan 27, 2023
S-8 Employee stock plan registration Jan 4, 2023 —
10-K Annual report Jan 4, 2023 Oct 31, 2022
8-K Current report
Regulation FD disclosure
Dec 8, 2022 Dec 8, 2022
8-K Current report
Regulation FD disclosure
Sep 29, 2022 Sep 28, 2022
EFFECT Filing Sep 19, 2022 —
CORRESP Letter to the SEC Sep 15, 2022 —
UPLOAD Letter from the SEC Sep 14, 2022 —
DEL AM Filing Sep 12, 2022 —
S-3 Shelf registration Sep 9, 2022 —
10-Q Quarterly report Sep 9, 2022 Jul 31, 2022
8-K Current report
Other events
Aug 17, 2022 Aug 15, 2022
10-Q Quarterly report Jun 10, 2022 Apr 30, 2022
8-K Current report
Officer or director change
Apr 15, 2022 Apr 14, 2022
8-K Current report
Shareholder vote results, Regulation FD disclosure
Mar 11, 2022 Mar 10, 2022
10-Q Quarterly report Mar 11, 2022 Jan 31, 2022
DEF 14A Proxy statement Jan 28, 2022 Jan 28, 2022
S-8 Employee stock plan registration Jan 4, 2022 —
10-K Annual report Jan 4, 2022 Oct 31, 2021
8-K Current report Dec 9, 2021 Dec 7, 2021
8-K Current report
Regulation FD disclosure
Oct 28, 2021 Oct 26, 2021
8-K Current report
Other events
Oct 4, 2021 Oct 1, 2021
10-Q Quarterly report Sep 1, 2021 Jul 31, 2021
8-K Current report
Agreement ended
Jun 16, 2021 Jun 16, 2021
10-Q Quarterly report Jun 10, 2021 Apr 30, 2021
8-K Current report
Shareholder vote results, Regulation FD disclosure
May 27, 2021 May 21, 2021
DEF 14A Proxy statement Apr 9, 2021 Apr 9, 2021
8-K Current report
Officer or director change, Bylaw or fiscal year change
Apr 2, 2021 Mar 29, 2021
PRE 14A Preliminary proxy statement Mar 30, 2021 Mar 30, 2021
8-K Current report
Material agreement
Mar 24, 2021 Mar 22, 2021
424B5 Prospectus supplement Mar 24, 2021 —
FWP Free writing prospectus Mar 23, 2021 —
FWP Free writing prospectus Mar 22, 2021 —
424B5 Prospectus supplement Mar 22, 2021 —
10-Q Quarterly report Mar 11, 2021 Jan 31, 2021
8-K Current report
Material agreement
Jan 28, 2021 Jan 26, 2021
S-8 Employee stock plan registration Jan 7, 2021 —
10-K Annual report Jan 7, 2021 Oct 31, 2020
8-K Current report
Material agreement
Dec 1, 2020 Nov 30, 2020
8-K Current report
Regulation FD disclosure
Sep 16, 2020 Sep 16, 2020
10-Q Quarterly report Sep 8, 2020 Jul 31, 2020
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Aug 17, 2020 Aug 13, 2020
DEFA14A Additional proxy material Jul 20, 2020 —
DEF 14A Proxy statement Jul 2, 2020 Jul 2, 2020
8-K Current report
Other events
Jul 2, 2020 Jul 2, 2020
PRE 14A Preliminary proxy statement Jun 22, 2020 Jun 22, 2020
10-Q Quarterly report Jun 9, 2020 Apr 30, 2020
8-K Current report
Material agreement
Apr 20, 2020 Apr 14, 2020
10-Q Quarterly report Mar 9, 2020 Jan 31, 2020
10-K/A Amended annual report Jan 10, 2020 Oct 31, 2019
424B3 Prospectus Jan 9, 2020 —
10-K Annual report Jan 9, 2020 Oct 31, 2019
8-K Current report
Shareholder vote results, Regulation FD disclosure
Oct 24, 2019 Oct 23, 2019
DEF 14A Proxy statement Sep 12, 2019 Sep 12, 2019
10-Q Quarterly report Sep 6, 2019 Jul 31, 2019
8-K Current report
Other events
Aug 27, 2019 Aug 21, 2019
8-K Current report
Regulation FD disclosure
Aug 21, 2019 Aug 21, 2019
8-K Current report
Material agreement
Jul 18, 2019 Jul 12, 2019
EFFECT Filing Jun 21, 2019 —
CORRESP Letter to the SEC Jun 19, 2019 —
UPLOAD Letter from the SEC Jun 18, 2019 —
10-Q Quarterly report Jun 12, 2019 Apr 30, 2019
S-3 Shelf registration Jun 11, 2019 —
8-K Current report
Regulation FD disclosure
May 23, 2019 May 23, 2019
10-Q Quarterly report Mar 13, 2019 Jan 31, 2019
8-K Current report
Other events
Jan 25, 2019 Jan 25, 2019
10-K Annual report Jan 11, 2019 Oct 31, 2018
S-8 Employee stock plan registration Oct 1, 2018 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
Oct 1, 2018 Sep 27, 2018
8-K Current report
Regulation FD disclosure
Sep 27, 2018 Sep 27, 2018
10-Q Quarterly report Sep 7, 2018 Jul 31, 2018
DEF 14A Proxy statement Aug 17, 2018 Aug 17, 2018
8-K Current report
Other events
Jul 27, 2018 Jul 26, 2018
10-Q Quarterly report Jun 11, 2018 Apr 30, 2018
8-K Current report
Officer or director change
May 14, 2018 May 8, 2018
8-K Current report
Shareholder vote results
Apr 2, 2018 Mar 29, 2018
8-K Current report
Material agreement
Mar 27, 2018 Mar 27, 2018
424B5 Prospectus supplement Mar 27, 2018 —
10-Q Quarterly report Mar 9, 2018 Dec 1, 2017
8-K Current report
Other events
Mar 5, 2018 Mar 5, 2018
CT ORDER Filing Feb 15, 2018 —
S-8 Employee stock plan registration Feb 14, 2018 —
DEF 14A Proxy statement Feb 12, 2018 Feb 12, 2018
PRE 14A Preliminary proxy statement Jan 26, 2018 Jan 26, 2018
8-K Current report
Officer or director change
Jan 23, 2018 Jan 17, 2018
10-K Annual report Jan 9, 2018 Oct 31, 2017
8-K Current report
Agreement ended
Dec 12, 2017 Dec 7, 2017
8-K Current report
Material agreement
Nov 22, 2017 Nov 17, 2017
8-K Current report
Material agreement
Nov 17, 2017 Nov 13, 2017
8-K Current report
Material agreement
Nov 17, 2017 Nov 13, 2017
424B5 Prospectus supplement Nov 17, 2017 —
EFFECT Filing Oct 26, 2017 —
CORRESP Letter to the SEC Oct 24, 2017 —
UPLOAD Letter from the SEC Oct 23, 2017 —
S-3 Shelf registration Oct 16, 2017 —
8-K Current report
Other events
Oct 3, 2017 Oct 2, 2017
8-K Current report
Material agreement
Sep 29, 2017 Sep 28, 2017
424B5 Prospectus supplement Sep 29, 2017 —
8-K Current report
Shareholder vote results
Sep 27, 2017 Sep 22, 2017
10-Q Quarterly report Sep 8, 2017 Jul 31, 2017
8-K Current report
Listing notice
Aug 24, 2017 Aug 18, 2017
8-K Current report
Other events
Aug 18, 2017 Aug 16, 2017
DEF 14A Proxy statement Aug 8, 2017 Sep 22, 2017
8-K Current report
Officer or director change
Jul 21, 2017 Jul 17, 2017
8-K Current report
Officer or director change
Jul 12, 2017 Jul 6, 2017
8-K Current report
Regulation FD disclosure
Jun 2, 2017 May 31, 2017
10-Q Quarterly report May 26, 2017 Apr 30, 2017
8-K Current report
Material agreement
May 17, 2017 May 16, 2017
424B2 Prospectus May 15, 2017 —
424B2 Prospectus May 11, 2017 —
8-K Current report
Other events
Apr 13, 2017 Apr 10, 2017
EFFECT Filing Apr 10, 2017 —
CORRESP Letter to the SEC Apr 6, 2017 —
8-K Current report
Regulation FD disclosure
Apr 5, 2017 Apr 4, 2017
UPLOAD Letter from the SEC Apr 3, 2017 —
S-3 Shelf registration Mar 31, 2017 —
RW Request withdrawal of s-1 file no. 333-215799 Mar 27, 2017 —
10-Q Quarterly report Mar 16, 2017 Jan 31, 2017
8-K Current report
Material agreement
Mar 8, 2017 Mar 3, 2017
424B2 Prospectus Mar 6, 2017 —
8-K Current report
Regulation FD disclosure
Feb 14, 2017 Feb 10, 2017
CT ORDER Filing Feb 1, 2017 —
S-1 Registration statement Jan 27, 2017 —
8-K Current report
Regulation FD disclosure
Jan 19, 2017 Jan 19, 2017
10-K/A Amended annual report Dec 8, 2016 Oct 31, 2016
8-K Current report
Other events
Dec 7, 2016 Dec 7, 2016
10-K Annual report Dec 7, 2016 Oct 31, 2016
8-K Current report
Officer or director change
Oct 21, 2016 Oct 17, 2016
8-K Current report
Other events
Oct 18, 2016 Oct 17, 2016
8-K Current report
Listing notice, Shareholder vote results
Aug 26, 2016 Aug 23, 2016
10-Q Quarterly report Aug 19, 2016 Jul 31, 2016
DEFA14A Additional proxy material Jul 5, 2016 —
DEF 14A Proxy statement Jul 5, 2016 Aug 23, 2016
10-Q Quarterly report May 20, 2016 Apr 30, 2016
10-Q Quarterly report Feb 19, 2016 Jan 31, 2016
EFFECT Filing Feb 2, 2016 —
POS AM Filing Jan 25, 2016 —
10-K Annual report Dec 23, 2015 Oct 31, 2015
8-K Current report
Material agreement
Oct 2, 2015 Oct 2, 2015
424B5 Prospectus supplement Oct 2, 2015 —
EFFECT Filing Sep 18, 2015 —
CORRESP Letter to the SEC Sep 16, 2015 —
S-3/A Form s-3/a Sep 14, 2015 —
UPLOAD Letter from the SEC Sep 10, 2015 —
S-3 Shelf registration Sep 4, 2015 —
8-K Current report
Shareholder vote results
Sep 1, 2015 Aug 26, 2015
10-Q Quarterly report Aug 18, 2015 Jul 31, 2015
DEFA14A Additional proxy material Jul 16, 2015 —
DEF 14A Proxy statement Jul 16, 2015 Aug 26, 2015
CERTNAS Auto-generated paper document Jul 9, 2015 —
8-K Current report
Listing notice
Jul 9, 2015 Jul 9, 2015
8-A12B Form 8-a Jul 9, 2015 —
8-K Current report
Bylaw or fiscal year change
Jun 25, 2015 Jun 25, 2015
8-K Current report
Regulation FD disclosure
Jun 23, 2015 Jun 23, 2015
10-Q Quarterly report May 22, 2015 Apr 30, 2015
EFFECT Filing Mar 19, 2015 —
POS AM Filing Mar 18, 2015 —
AW Form aw Mar 18, 2015 —
EFFECT Filing Mar 13, 2015 —
CORRESP Letter to the SEC Mar 11, 2015 —
10-Q Quarterly report Mar 9, 2015 Jan 31, 2015
POS AM Filing Mar 4, 2015 —
S-1/A Amended registration statement Mar 4, 2015 —
CORRESP Letter to the SEC Mar 3, 2015 —
S-8 Employee stock plan registration Mar 3, 2015 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANIX (Nasdaq)
Fiscal year ends
October 31
Incorporated in
DE
Headquarters
San Jose, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
715446
Former names
ITUS Corp (until Sep 27, 2018); COPYTELE INC (until Aug 27, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.